We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Bodisen | LSE:BODI | London | Ordinary Share | COM STK USD0.0001 |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 6.00 | 0.00 | 01:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 6.00 | GBX |
Bodisen Biotech (BODI) Share Charts1 Year Bodisen Biotech Chart |
|
1 Month Bodisen Biotech Chart |
Intraday Bodisen Biotech Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 24/7/2014 | 08:49 | BODI - literally a bag of shit | 308 |
| 27/1/2008 | 13:08 | Literally An Organic Growth Stock | 413 |
| 19/10/2006 | 10:50 | BODI with Charts & News | 4 |
| 03/5/2006 | 21:44 | A great investment opporyunity -BUY | 5 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 16/5/2014 20:47 by skier100 Question for BODI long-termers -- what, in your view, drove the spike in trading volumes and share price today?Thanks in advance. |
Posted at 18/4/2011 21:24 by mattjos On 'dog' stocks you'd expect the stochastic to sit on the floor for long periods and only come to life either side of scheduled announcements. This one never sits on the bottom for longer than a day or so before it sets off north again.I've been watching the trading in the usa for months now. The pattern is constant: Buyer probes the Offer with a parcel of 300/500 shares. Then he sits back and waits for the Bid to get raised and some stock to come tumbling down .. day or so later he picks all the stock and then goes probing again & repeat. It's been constant and, imo, the stock is under accumulation - irrespective of the fundamentals, the history, whatever else you look at. Bodisen appears to have several assets that i can conceive as being sought after - 1. The stake in CPDU 2. The new 200kt factory in Xinjiang province 3. Carry forward tax losses 4. The OTC listing itself Something seems to be afoot & it is unfolding on the usa listing at present .... i believe the uk price should get drawn up nearer to parity given the action in the usa. |
Posted at 13/4/2011 02:00 by mattjos interesting 1st Q results from peer Yongye:Yongye International, Inc. (NASDAQ: YONG), a leading agricultural nutrient company in China ("Yongye" or the "Company"), today announced preliminary financial results for the first quarter of 2011. The Company's revenues for the three months ended March 31, 2011, were $50.2 million, more than double last year's first quarter revenues of $24.9 million. The significant increase in revenues was driven by higher demand for the Company's products in its traditional markets, and growth in several new markets. In addition, after the acquisition of the Hebei customer list in July 2010, the Company is selling its products at a higher price directly to lower level distributors in Hebei, which is Yongye's largest regional market in China. As of March 31, 2011, Yongye had 26,006 independently-owned branded stores in its network, compared to 24,036 stores at the end of 2010. In addition, during the first quarter of 2011, the Company achieved positive cash flow from operations. For full year 2011, the Company continues to expect revenues of between $315 million and $325 million, representing an increase of 47.1% and 51.8% over 2010's revenue of $214.1 million. The Company expects adjusted net income attributable to Yongye, which excludes non-cash expenses related to share-based compensation for management and independent directors, the amortization of the acquired Hebei customer list, and a change in the fair value of derivative liabilities, of between $80 million and $82 million, representing an increase of between 47.9% and 51.6% over 2010 adjusted net income attributable to Yongye of $54.1 million. The Company has a year-end target of at least 30,000 for the number of independently-owned, branded stores selling Yongye's Shengmingsu products. "We are pleased with our first quarter sales and cash flow results," stated Mr. Zishen Wu, Chairman and Chief Executive Officer. "As many of our investors know, our first and fourth quarters are seasonally our slowest. Nevertheless, we were able to achieve strong sales growth as a result of continued demand for our Shengmingsu agricultural nutrient products from Chinese farmers in both new and existing provinces. Also of importance, we achieved positive cash flow from operations as a result of our improved working capital management, while more than doubling our sales year-over-year." Mr. Wu concluded, "Our management team and board of directors are committed to enhancing shareholder value and are confident in the long-term health and future financial performance of our business. Based on current market prices, we believe that our shares are presently undervalued in the marketplace. Our board of directors is contemplating various alternatives to address this issue and will make an announcement as soon as the board determines the appropriate course of action." The results announced in this press release are unaudited. The Company plans to release its first quarter 2011 financial results in May 2011. |
Posted at 15/2/2011 08:01 by mattjos keya .. book value in the usa is $2.50 ... i don't expect that sort of price for a while yet but, this stock has historically been heavily shorted in the usa. if the shorts have to start closing, who knows where it will go.am really waiting for news from CPDU which will influence how quickly BODI can realise the value of its stake there + progress on the new plant in Xinjiang. meantime, it simply looks too cheap - so, I've been a buyer |
Posted at 14/2/2011 15:50 by mattjos now at 22p to buy .... or 35c equivalent .... less than half price still relative to the usa. |
Posted at 08/2/2011 12:07 by mattjos I'm curious as to why this RNS has not been made here in the UK."ITEM 4. PURPOSE OF TRANSACTION. William H. Brandt (WHB) wants the Company to grow through prudent mergers and acquisitions in China's fertilizer industry. WHB suspects that the Company is a victim of a Wall Street manipulation scheme. WHB intends to buy more BBCZ shares. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. The Reporting Person is a nominee for William H. Brandt (WHB). 1.2 million BBCZ shares is 6.4% of the last-reported total outstanding. The shares were accumulated over several years at an estimated cost-basis of less than $1.00 per share through open-market purchases." That is a significant stake for an individual to build up in this company and over such a long period of time & seems to have gone largely unnoticed over here. I'm struggling to see where the trading volume has been, over the last 2 years even, to have enabled that sort of stake building for anything less than an average of say $0.75 .... so 1.2m x $0.75 = $900k. This person has even indicated in the announcement that he intends to buy more stock here. Now that seems to be a peculiar statement to make if he wishes to continue accumulating at a cheap price. Alternatively he is flagging the intent with a view to try and move the price up but, i can't see how he could then consider dumping 1.2m shares into the market if this is a stunt .. there is not the liquidity at present. so what is going on here, is the question i ask myself? is this guy trying to buy himself a seat on the board with a view to follow through on his intent that Bodisen ".... grow through prudent mergers and acquisitions in China's fertilizer industry." The stock is highly illiquid & arguably much of the supply (at these levels) has now been taken up. Even my few share purchases in the last few months have moved the market here on each occasion. Any indications of a sustained/significan Meantime we await devts with the stake in CPDU and whether/when Bodisen can realise it if CPDU proceed with their intent to list on the NASDAQ ... CPDU itself seem to performing well in their business. Just a pity about the hideous spread here |
Posted at 08/6/2010 14:04 by mrstock Anybody got a reasonably recent report on this company? Any chance of a pick up in stock price seen here? |
Posted at 04/10/2006 11:02 by cimbom This should answer alot of the questions that were asked here yesterday.Bodisen Biotech: The Little Fertilizer Company That Could Posted on Oct 3rd, 2006 with stocks: BBC David Phillips (10Q Detective) submits: Investors in Bodisen Biotech, Inc. (BBC), a manufacturer of organic fertilizers and pesticides targeting Chinese agricultural markets, saw the value of their holdings' lose about 17% last week, as the Company's past relationship with a 'colorful' adviser to emerging Chinese companies came to light. Bodisen Biotech has since ended its relationship with the advisor, Benjamin Wey, and New York Global Group. In addition to public relations work here in the U.S., according to an SB-2/A filed with the SEC in February 2006, the Company had an oral agreement with the Beijing office of New York Global Capital, Inc. for the payment of a corporate finance fee of $300,000 for help Bodisen acquire a dual listing on the London Stock Exchange. Company and Market Description Emerging from the shell of a start-up stage Internet-based commercial mortgage originator called Stratabid.com, Inc., Bodisen is now a highly profitable, one stop solution provider of the entire planting needs for Chinese farmers. With over 60 different products (sold in all seasons) in four categories: compound fertilizers, liquid fertilizers, pesticides, and agricultural raw materials, the Company has enjoyed-on average-a net margin of approximately 30% across its product lines. The 10Q Detective first learned of Bodisen when we did our due diligence on China Natural Gas (CHNG), because the Company beneficially owns approximately 2.03 million, or about nine percent, of the Common Stock of CHNG (at $1.39 per share). Through the investment, Bodisen is looking to leverage CHNG's relationships with urea suppliers to obtain price discounts. Urea is a natural gas byproduct used in fertilizer production. Bodisen's organic products have many advantages over chemical fertilizers. Its fertilizer products improve crop yields by 10% to 35% and are sold at prices similar to chemical fertilizers. Additionally, Chinese farmers that use Bodisen's organic fertilizer can have their fruits and vegetables government certified as "organic produce," which command as much as 200% higher in retail prices compared to non-organic produce, therefore substantially increasing farmers' income levels. Bodisen's compound fertilizer products offer ease of use, because they are applied one time while each type of chemical fertilizers may have to be applied separately. The Company is growing its business in a favorable market environment. The agricultural industry is strongly supported by the Chinese government. China, with 1.3 billion people, is one of the largest importers of grains in the world. Much of China's urban population of 500 million depends on imported grains to support higher demand for meat. In order to reduce dependence on foreign grains, the Chinese government supports the agricultural industry by providing many incentives to agricultural product companies. Bodisen enjoys tax-free status and is exempt from sales tax, VAT, agricultural product tax and income tax (income tax holiday through the end of 2007 and renewable thereafter). Financial Analysis The Company generated revenues of $26.9 million for the six months ended June 30, 2006, an increase of about $13.8 million, or 105.3%, compared to $13.1 million for the prior year period. Management believes that the strong first half of the year was made possible by repeat business from a loyal base of customers buying more items from Bodisen's product line (as they keep achieving greater crop yields). Gross margin, as a percentage of revenues, increased from 37.4% for the six months ended June 30, 2005, to 39.6% for the six months ended June 30, 2006. The increase in gross margin was primarily attributable to an across the board increase in the selling price of its products. Comprehensive income increased by 117.1% to $7.6 million (share-net of $0.48) during the six months ended June 30, 2006, as compared to $3.5 million (share-net of $0.22) for last year. The increase was attributed to a successful marketing campaign focused on increasing cross selling of all Bodisen's products to its customer base, and growing demand in new markets and regions throughout China. The Company also benefited from a prudent decision made in December 2005 to lock in raw material costs before cost increases were announced in the 1H:06. [Ed. note. Talk about controversy! On December 8, 2005, Bodisen issued a $5.0 million promissory note to Amaranth Partners L.L.C. The obligation was used to lock in hedges against the aforementioned raw material cost increases in the current fiscal year. Amaranth Partners L.L.C. is a Delaware-registered subsidiary of the Greenwich, Conn.-based hedge fund Amaranth Advisors that collapsed after a misplaced bet on natural gas! The loan has since been paid back. However, in connection with the issuance of the Note, the Company agreed to issue to Amaranth a warrant to purchase 133,333 shares of the Company's common stock at $7.50 per share (subject to adjustment). Given the liquidation going on over at Amaranth, one would suspect that these shares will hit the market--putting some short-term pressure on the price of Bodisen, too.] Accounts receivables rose by $10.0 million in the 1H:06, resulting in negative cash flow from operations of about $(3.7) million. The Company also advances credit to certain vendors for purchase of its material. The advances to suppliers are interest free and unsecured. The advances to suppliers amounted to $9.9 million at June 30, 2006. Although red flags do exist, in our view, we can shrug them off (for now) because the Company does have a strong balance sheet without any long-term debts. As of June 30, 2006, working capital was $29.0 million (net unsecured advances to suppliers and monies kept in a bank account for investment in a new compound fertilizer plant in Xinjiang Province A La Er City). Book value stood at $3.36 per share. Valuation Analysis In a short time the Company has gained a reputation for producing "green" products that address farmers' concerns in a market that is growing exponentially. Bodisen could easily earn $1.00 per share this fiscal year and is selling for a fraction of the [TTM] 36.5 and 22.5 P/E multiples commanded by agri-chemical giants Monsanto Co. (MON) and Swiss Syngenta AG (SYT), respectively. The 10Q Detective prefers to look beyond Bodisen's short-term worries, because we see a favorable profit picture in this Company's future (forward five-year average growth of about 35 percent per annum). Bodisen has one of the largest Chinese agricultural product distribution networks. The Company has Product Sale Agreements with more than 155 wholesalers in addition to the current potential to reach more than 60% of China's agricultural markets. As previously mentioned, the Company is building a new compound fertilizer plant in Xinjiang Province. Our two-year target price is $26.00 per share, which implies (among other variables) the issuance of an additional seven million shares for future capex needs; the Company growing at 35% per annum; gross margins of at least 36.7%; equity risk premium of 5.0%; and an assumed WACC of 10 percent. Investment Risks and Considerations Risks to our opinion include gross margins squeezed by unanticipated raw material cost increases; unexpected competition from international agri-chemical giants; and, pricing power erosion related to declining economic benefits to farmers (defined in terms of crop yield and prices). Management owns a significant amount of the Common Stock, giving them influence or control in corporate transactions and other matters, and their interests could differ from those of other stockholders. Two of Bodisen's principal executive officers, CEO Wang Qiong and President Chen Bo, collectively own approximately 45.48% of the Existing Common Stock. As a result, they are in a position to significantly influence or control the outcome of matters requiring a stockholder vote, including the election of directors and the approval of significant corporate transactions. Bodisen's financial success depends upon the development of The People's Republic of China's agricultural industry. Roughly half of the PRC's labor force is engaged in agriculture, even though only about 10% of the land is suitable for cultivation. Although the PRC hopes to further increase agricultural production, incomes for Chinese farmers are stagnating. Despite the Chinese government's continued emphasis on agricultural self-sufficiency, an inadequate infrastructure, from port facilities to a lack of warehousing and cold storage facilities impedes the domestic agricultural trade. Bodisen relies on local farmers to purchase its products, which are generally purchased under a "Cash on Delivery" or (as previously mentioned) on a 9-12 months credit; the farmers' inability to sell their agricultural goods could therefore hinder their ability to timely pay their credit obligations to the Company. Of concern, in the 2Q:06, days-of-sales outstanding jumped almost 21 days to 97 days (as compared to the 2Q:05). To our new readers, this means that it is taking longer for Bodisen to collect on what it is owed by its customers-indicative of an 'easy money' lending policy? Management does note, however, in its SEC filings that credit terms of the sales vary from COD through a credit term up to 9 to 12 months. However, should central China be hit with an 'Act of God'--floods, drought, or locusts--the allowance for doubtful accounts of $697,209 might prove to be woefully inadequate. The People's Republic of China's Economic Policies could also affect the Company's business. Substantially all of the Company's assets are located in the PRC and substantially all of its revenue is derived from operations in the PRC. Accordingly, results of operations and prospects are subject, to a significant extent, to the economic, political and legal developments in the PRC. BBC 1-yr chart: Editor David J Phillips is long shares of Bodisen Biotech and China Natural Gas but has no financial interest in any other company mentioned in this posting. The 10Q Detective has a full disclosure policy. |
Posted at 15/8/2006 14:12 by cimbom Bodisen Biotech to Present at the Roth Capital Partners 2006 New York Conference in Early SeptemberNEW YORK, NY -- (MARKET WIRE) -- August 15, 2006 -- Bodisen Biotech, Inc. (AMEX: BBC) (AIM: BODI) (website: www.bodisen.com), the first China-based environmentally friendly bio fertilizer company listed on a U.S. stock exchange, and dually listed in London, today announced that it will present at the Roth Capital Partners 2006 New York Conference. The conference is being held September 6-7, 2006 at the Westin Times Square Hotel in New York City. Chairman and Chief Executive Officer, Karen Qiong Wang, and President Bo Chen will present at 1:30 p.m. Eastern Time on Wednesday, September 6, 2006. Karen Qiong Wang, Chairman & CEO of Bodisen, commented, "We look forward to having this opportunity to share Bodisen's bright outlook with investors and also highlight the tremendous earnings growth that the Company has been able to deliver quarter after quarter over the past two and a half years since becoming a public company. We expect our recent expansion into China's vast Xinjiang province to contribute significantly to our 2007 earnings and beyond. Bodisen's management team is focused on executing another excellent quarter for the third quarter especially given that we are already in the middle of our third quarter, which historically has been our strongest quarter of the year." On August 14, 2006, Bodisen reported record revenues of $16.4 million for the second quarter of 2006, up 95% from the prior year period and net income of $5.9 million (or fully diluted EPS of $0.32), up 118% from the prior year period. The Company also cited positive growth outlook for the second half of 2006 and 2007 given strong product demand and Bodisen's strategic expansion into new markets. A live webcast of the audio presentation will be available along with accompanying presentation slides. Interested parties may tune in to the live presentation by visiting: About Bodisen Biotech, Inc. A Delaware company, Bodisen is headquartered in Shaanxi, China's agricultural hub. In January 2006, Bodisen was ranked the 16th fastest growing company in China by Forbes China. The Bodisen brand is a highly recognized fertilizer brand in China. Its environmentally friendly "green" products support the mandate of the Chinese government to increase crop yields for the purpose of decreasing China's dependency on food imports. Utilizing proprietary agricultural technologies, Bodisen sells over 60 packaged products, broken down into 4 product categories: Organic Compound Fertilizer; Organic Liquid Fertilizer; Pesticides & Insecticides; and agricultural raw materials. Bodisen's organic fertilizers are government certified as "organic" and can be absorbed by plants within 48 hours and enrich soil conditions without the damaging effects associated with chemical fertilizers. Bodisen's products address grains, vegetables, and fruit crops and have been proven to increase crop yields by 10% to 35% while being environmentally friendly. Among China's population of 1.3 billion, approximately 750 million are farmers or have agriculture related jobs whose incomes depend on their crop yields. With approximately 600 (and growing) nationwide distribution centers, Bodisen has experienced rapid growth. Safe Harbor Statement This press release may contain forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on the current expectations or beliefs of Bodisen Biotech, Inc. management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. -------------------- Investor Relations: Debra Chen The Piacente Group, Inc. 212-481-1907 SOURCE: Bodisen Biotech, Inc. -------------------- Back To Recent News Issuers of news releases, not Market Wire, are solely responsible for the accuracy of the content. |
Posted at 03/4/2006 14:02 by krishall RNS Number:8489ABodisen Biotech Inc 03 April 2006 Bodisen Biotech Inc ("Bodisen") Trading Update NEW YORK--(BUSINESS WIRE) - April 3, 2006 -- Bodisen Biotech, Inc., (AMEX:BBC, London AIM:BODI, website: www.bodisen.com), the first China based environmentally friendly bio fertilizer company listed on a US stock exchange, and dually listed in London, announced today that the company experienced strong sales in the first quarter of 2006. Bodisen sees record earnings for the quarter ended March 31, 2006. In the first quarter that ended on March 31, 2005, Bodisen reported total revenues of $4,701,675 and net income of $796,733, or $0.05 fully diluted earnings per share. On the First Quarter Earnings Karen Qiong Wang, CEO of Bodisen commented: "In 2005, Bodisen reported a year of record sales and earnings. The 4th quarter of each year is historically the slowest period for the agricultural industry due to the frozen winter season and less farming activities. Our earnings in 2005 would have been approximately $570,000 ($0.04 per share) higher, had we not spent critically important marketing expenses in the 4th quarter of 2005 for 2006 related marketing efforts in anticipation of strong growth in 2006. With a sound marketing program in place, we started the 2006 planting season with a strong balance sheet, abundant capital without additional funding needs, deeper market penetration and a strong nationally recognized "Bodisen" brand, which we believe will result in continued rapid growth for the company in 2006. Our factories are operated around the clock to keep up with growing customer demand. We look forward to reporting record earnings for our first quarter and building on this growth in the upcoming second and third quarters, which typically are our strongest quarters of the year." 2006 Guidance and Update Ms. Wang said,"Since entering the public market in March 2004, Bodisen has consistently achieved high double digit year-over-year sales and earnings growth. With more than 60 products, enhanced brand recognition, an extensive distribution network, strong market demand for organic bio-fertilizers and sufficient capital resources, we expect to continue to achieve strong year-over-year revenue and earnings growth in 2006." "In November 2005, we received $43 million in signed orders for 2006 at two large industry trade shows, which we believe represent approximately 70% of our expected annual sales in 2006 and already exceeds our 2005 reported revenues of approximately $31.0 million. In 2006, we expect to at least double our 2005 sales volume while targeting net margin of approximately 30%. As Chinese farmers increasingly transition from chemical fertilizers to more cost-effective, higher yield and environmentally friendly organic bio-fertilizers, Bodisen is well-positioned to benefit from this favorable market environment. With an extensive market reach covering almost 60% of China, Bodisen is able to supply farmers with complete agricultural product solutions that meet their changing needs throughout the year," said Ms. Wang. In addition to its expected revenue growth and net margin performance, the company stated that its 2006 plans include the completion of two manufacturing facilities in the northeast and northwest regions of China, which are two of the largest farming areas in China. Bodisen already has established distribution channels in these areas through sales of its high margin liquid fertilizers. The facilities are expected to be up and running in 2006, in time for the 2007 planting season product sales. Bodisen believes that the added capacity could potentially double the company's sales in 2007 compared to 2006. China is the largest fertilizer market in the world with a total market size of approximately $17 billion annually for agricultural products. Bodisen has considerable room for growth for many years to come. "After completing extensive due diligence on our business and financials led by global law firms Jones Day, ReedSmith and accounting firm Deloitte & Touche, we completed our dual listing in London during the first quarter. The successful dual listing not only provided Bodisen with growth capital and greater name exposure but also opened up new potential product distribution channels for the company as Bodisen receives more and more product requests from European and other international markets. Today, Bodisen is a strong company with a focused management team and no plans to dilute existing shares. The company has a strong and successful operations model capable of sustaining our rapid growth in 2006, 2007 and beyond." said Ms. Wang. About Bodisen Biotech, Inc. A Delaware company, Bodisen is headquartered in Shaanxi, China's agricultural hub. In January 2006, Bodisen was ranked the 16th fastest growing company in China by Forbes China. The Bodisen brand is a highly recognized fertilizer brand in China. Its environmentally friendly "green" products support the mandate of the Chinese government to increase crop yields for the purpose of decreasing China's dependency on food imports. Utilizing proprietary agricultural technologies, Bodisen sells over 60 packaged products, broken down into 4 product categories: Organic Compound Fertilizer; Organic Liquid Fertilizer; Pesticides & Insecticides, and agricultural raw materials. Bodisen's organic fertilizers are government certified as "organic" and can be absorbed by plants within 48 hours and enrich soil conditions without the damaging effects associated with chemical fertilizers. Bodisen's products address grains, vegetables, and fruit crops and have been proven to increase crop yields by 10% to 35% while being environmentally friendly. Among China's population of 1.3 billion, approximately 900 million are farmers or have agriculture related jobs whose incomes depend on their crop yields. With approximately 600 (and growing) nationwide distribution centers, Bodisen has experienced rapid growth. Safe Harbor Statement This press release may contain forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on the current expectations or beliefs of Bodisen Biotech, Inc. management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Charles Stanley Securities Richard Thompson/ Freddy Crossley +44 (0) 20 7953 2000 First City Public Relations Allan Piper +44 (0) 20 7436 7486 / +44 (0) 7736 064 982 Jiang Lee +85 2 6419 2915 This information is provided by RNS The company news service from the London Stock Exchange |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
